The Center Faculty come from all four UCSF Schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

Stuart Gansky, MS, DrPH

Preventive & Restor Dent Sci

Oral health research, health disparities research, applied statistical analyses and related methodological issues.

Peter Ganz, MD

Professor in Residence

Cardiovascular effects and potential harms of conventional, new and emerging tobacco products.

Warren Gold, MD

Professor Emeritus

Long-term effects of second hand cigarette smoke on flight attendants.

Scarlett Gomez, PhD, MPH

Epidemiology & Biostatistics

The role of social determinants of health, including race/ethnicity, socioeconomic status, gender, immigration status, sociocultural factors, and neighborhood contextual characteristics, on health outcomes.

Jeffrey Gotts, MD, PhD

Assistant Professor

Effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.

Jennifer Grandis, MD

Professor, Otolaryngology – Head and Neck Surgery, Associate Vice Chancellor, Clinical and Translational Science Institute

Signal transduction in head and neck squamous cell carcinoma (tobacco-caused cancers) development and progression with the ultimate goal of targeting key pathways for therapeutic benefit.

Lawrence Green, DrPH, MPH

Adjunct Professor
Epidemiology & Biostatistics

Health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies in making practice more evidence-based by making evidence more practice-based.

Valerie Gribben, MD

HS Assoc Clinical Professor

Valerie Gribben, MD, FAAP is an Assistant Professor of Pediatrics at UCSF.  Research interests include: reducing primary and secondhand vaping, cigarette, and marijuana exposure in children and teens; vaping patterns of teenagers during the COVID-19 pandemic; the intersection between digital usage and vaping; social media interventions to assist in vaping cessation; and health disparities in tobacco use and exposure. 

Joe Guydish, PhD

Institute for Health Policy Studies

Access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings with current focus an organizational change intervention for treatment programs in tobacco dependence.

Sharon Hall, PhD

Professor Emeritus

Clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations.